MidCap Increases Revolving Loan Commitment by $5MM for Medexus
As part of an amendment to Medexus Pharmaceuticals’ revolving credit facility, MidCap Funding IV Trust increased its loan commitment by $5 million, bringing the total facility’s capacity to $25 million.
September 30, 2022
Marcel Konrad | Medexus Pharmaceuticals | MidCap Funding IV Trust
Phil Neuffer